Fig. 2From: α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progressionA to E shows steatosis is less severe in group of NETA + PD. A: group ND; B: group HFD; C: group NETA; D: group PD; E: group NETA + PDBack to article page